Laumas Sandeep bought UNCY
May 14, 2026 · Form 4 insider transaction
Laumas Sandeep bought 84,200 shares of Unicycive Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
84,200
Price
$0.00
Total value
N/A
InsiderLaumas Sandeep
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMay 14, 2026
Filing dateMay 18, 2026
Shares owned after84,200
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award vest 1/3 on the anniversary of the grant date for 3 years, subject to the Reporting Person's continued service with the Issuer.